Wang X, Sun L, Han X, Li Z, Xing Y, Chen X
Int J Mol Med. 2025; 55(4).
PMID: 39950327
PMC: 11878485.
DOI: 10.3892/ijmm.2025.5504.
Yang Y, Zhou H, Hong Z
Front Nutr. 2024; 11:1461748.
PMID: 39512517
PMC: 11541052.
DOI: 10.3389/fnut.2024.1461748.
Henderson J, OCallaghan J, Campbell M
Vision Res. 2024; 225:108502.
PMID: 39423611
PMC: 11579448.
DOI: 10.1016/j.visres.2024.108502.
Donkor N, Gardner J, Bradshaw J, Cunningham R, Inman D
Antioxidants (Basel). 2024; 13(7).
PMID: 39061946
PMC: 11273423.
DOI: 10.3390/antiox13070878.
Golmohammadi M, Meibodi S, Al-Hawary S, Gupta J, Sapaev I, Najm M
Animal Model Exp Med. 2024; 7(3):195-207.
PMID: 38808561
PMC: 11228121.
DOI: 10.1002/ame2.12438.
Neuroretinal Cell Culture Model as a Tool for the Development of New Therapeutic Approaches for Oxidative Stress-Induced Ocular Diseases, with a Focus on Glaucoma.
Fomo K, Perumal N, Manicam C, Pfeiffer N, Grus F
Cells. 2024; 13(9.
PMID: 38727311
PMC: 11083839.
DOI: 10.3390/cells13090775.
Assessment of Causality Between Diet-Derived Antioxidants and Primary Open-Angle Glaucoma: A Mendelian Randomization Study.
Xiong K, Zhang Q, Mao H, Congdon N, Liang Y
Transl Vis Sci Technol. 2024; 13(2):20.
PMID: 38411971
PMC: 10910435.
DOI: 10.1167/tvst.13.2.20.
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.
Caruso L, Fields M, Rimondi E, Zauli G, Longo G, Marcuzzi A
Int J Mol Sci. 2024; 25(4).
PMID: 38396799
PMC: 10889839.
DOI: 10.3390/ijms25042124.
Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage.
Fernandez-Albarral J, Ramirez A, de Hoz R, Matamoros J, Salobrar-Garcia E, Elvira-Hurtado L
Front Cell Neurosci. 2024; 18:1354569.
PMID: 38333055
PMC: 10850296.
DOI: 10.3389/fncel.2024.1354569.
Oxidative stress in the eye and its role in the pathophysiology of ocular diseases.
Bohm E, Buonfiglio F, Voigt A, Bachmann P, Safi T, Pfeiffer N
Redox Biol. 2023; 68:102967.
PMID: 38006824
PMC: 10701459.
DOI: 10.1016/j.redox.2023.102967.
Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment.
Buonfiglio F, Pfeiffer N, Gericke A
Pharmaceuticals (Basel). 2023; 16(9).
PMID: 37765001
PMC: 10535738.
DOI: 10.3390/ph16091193.
Neuroprotective effects of idebenone on hydrogen peroxide-induced oxidative damage in retinal ganglion cells-5.
Wang Y, Wang J, Zhang X, Feng Y, Yuan Y
Int Ophthalmol. 2023; 43(10):3831-3839.
PMID: 37561250
DOI: 10.1007/s10792-023-02831-x.
Oxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases?.
Buonfiglio F, Bohm E, Pfeiffer N, Gericke A
Antioxidants (Basel). 2023; 12(7).
PMID: 37508003
PMC: 10376185.
DOI: 10.3390/antiox12071465.
Mitochondria-associated endoplasmic reticulum membranes (MAMs) and their role in glaucomatous retinal ganglion cell degeneration-a mini review.
Pham J, Stankowska D
Front Neurosci. 2023; 17:1198343.
PMID: 37250427
PMC: 10213334.
DOI: 10.3389/fnins.2023.1198343.
The Role of Oxidative Stress in the Aging Eye.
Goodman D, Ness S
Life (Basel). 2023; 13(3).
PMID: 36983992
PMC: 10052045.
DOI: 10.3390/life13030837.
Calcium-Signalling in Human Glaucoma Lamina Cribrosa Myofibroblasts.
Irnaten M, OBrien C
Int J Mol Sci. 2023; 24(2).
PMID: 36674805
PMC: 9862249.
DOI: 10.3390/ijms24021287.
Anti-apoptotic and autophagic effect: Using conditioned medium from human bone marrow mesenchymal stem cells to treat human trabecular meshwork cells.
Chang Y, Cheng Y, Ko Y, Chiou S, Liu C
Regen Ther. 2023; 22:50-58.
PMID: 36618489
PMC: 9804247.
DOI: 10.1016/j.reth.2022.12.002.
Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2.
Pham J, Johnson G, Rangan R, Amankwa C, Acharya S, Stankowska D
Cells. 2022; 11(23).
PMID: 36497005
PMC: 9735605.
DOI: 10.3390/cells11233741.
Genome-Wide RNA Sequencing of Human Trabecular Meshwork Cells Treated with TGF-β1: Relevance to Pseudoexfoliation Glaucoma.
Roodnat A, Callaghan B, Doyle C, Henry M, Goljanek-Whysall K, Simpson D
Biomolecules. 2022; 12(11).
PMID: 36421707
PMC: 9687758.
DOI: 10.3390/biom12111693.